Career history of Thomas Byron Neff
Former positions of Thomas Byron Neff
| Companies | Position | Start | End |
|---|---|---|---|
| FIBROGEN, INC. | Chief Executive Officer | 1993-09-28 | 2019-08-26 |
| Chairman | 1993-09-28 | 2019-08-26 | |
| Founder | 1993-09-28 | 2019-08-26 | |
| Fibrogen China Anemia Holdings Ltd. | Director/Board Member | - | 2019-08-26 |
| Claremont McKenna College | Director/Board Member | - | 2019-08-26 |
Fibrogen Europe Oy
 Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland. | Director/Board Member | 1997-10-31 | 2019-08-26 |
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Director/Board Member | 2008-12-31 | 2015-12-31 |
Lazard Frères & Co. LLC
 Lazard Frères & Co. LLC Investment ManagersFinance Lazard Freres & Co. LLC provides corporate advisory, capital market, and asset management services. The company was founded on April 13, 1992 and is headquartered in New York, NY. | Corporate Officer/Principal | 1987-12-31 | - |
| Painewebber Group, Inc. | Corporate Officer/Principal | 1982-12-31 | - |
Training of Thomas Byron Neff
| Claremont McKenna College | Undergraduate Degree |
| The University of Chicago | Graduate Degree |
Statistics
International
| United States | 7 |
| Cayman Islands | 2 |
| Finland | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 4 |
| Finance | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Health Technology |
Lazard Frères & Co. LLC
Lazard Frères & Co. LLC Investment ManagersFinance Lazard Freres & Co. LLC provides corporate advisory, capital market, and asset management services. The company was founded on April 13, 1992 and is headquartered in New York, NY. | Finance |
| Painewebber Group, Inc. | Finance |
| Fibrogen China Anemia Holdings Ltd. | |
Fibrogen Europe Oy
Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland. | Health Technology |
- Stock Market
- Insiders
- Thomas Byron Neff
- Experience
